NGNE logo

Neurogene (NGNE) Cash From Operations

Annual CFO

-$51.42 M
+$1.40 M+2.65%

December 31, 2023


Summary


Performance

NGNE Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNGNEcash flowmetrics:

Quarterly CFO

-$15.56 M
+$329.00 K+2.07%

September 30, 2024


Summary


Performance

NGNE Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNGNEcash flowmetrics:

TTM CFO

-$70.08 M
-$4.00 M-6.05%

September 30, 2024


Summary


Performance

NGNE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNGNEcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NGNE Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.6%-34.5%-103.4%
3 y3 years-10.8%-14.8%-54.5%
5 y5 years-10.8%-14.8%-54.5%

NGNE Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.8%+2.6%-66.9%+51.1%-206.3%at low
5 y5-year-10.8%+2.6%-66.9%+51.1%-206.3%at low
alltimeall time-10.8%+2.6%-66.9%+51.1%-206.3%at low

Neurogene Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$15.56 M(-2.1%)
-$70.08 M(+6.0%)
Jun 2024
-
-$15.89 M(-26.6%)
-$66.08 M(+11.0%)
Mar 2024
-
-$21.65 M(+27.6%)
-$59.52 M(+15.7%)
Dec 2023
-$51.42 M
-$16.97 M(+46.7%)
-$51.42 M(+49.3%)
Sep 2023
-
-$11.57 M(+24.0%)
-$34.45 M(+50.6%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$9.33 M(-31.2%)
-$22.88 M(-49.6%)
Mar 2023
-
-$13.55 M(-57.4%)
-$45.36 M(+42.6%)
Dec 2022
-$52.82 M(+13.8%)
-
-
Jun 2022
-
-$31.81 M
-$31.81 M
Dec 2021
-$46.40 M
-
-

FAQ

  • What is Neurogene annual cash flow from operations?
  • What is the all time high annual CFO for Neurogene?
  • What is Neurogene annual CFO year-on-year change?
  • What is Neurogene quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Neurogene?
  • What is Neurogene quarterly CFO year-on-year change?
  • What is Neurogene TTM cash flow from operations?
  • What is the all time high TTM CFO for Neurogene?
  • What is Neurogene TTM CFO year-on-year change?

What is Neurogene annual cash flow from operations?

The current annual CFO of NGNE is -$51.42 M

What is the all time high annual CFO for Neurogene?

Neurogene all-time high annual cash flow from operations is -$46.40 M

What is Neurogene annual CFO year-on-year change?

Over the past year, NGNE annual cash flow from operations has changed by +$1.40 M (+2.65%)

What is Neurogene quarterly cash flow from operations?

The current quarterly CFO of NGNE is -$15.56 M

What is the all time high quarterly CFO for Neurogene?

Neurogene all-time high quarterly cash flow from operations is -$9.33 M

What is Neurogene quarterly CFO year-on-year change?

Over the past year, NGNE quarterly cash flow from operations has changed by -$4.00 M (-34.54%)

What is Neurogene TTM cash flow from operations?

The current TTM CFO of NGNE is -$70.08 M

What is the all time high TTM CFO for Neurogene?

Neurogene all-time high TTM cash flow from operations is -$22.88 M

What is Neurogene TTM CFO year-on-year change?

Over the past year, NGNE TTM cash flow from operations has changed by -$35.63 M (-103.42%)